XmAb5871 suppressed B cell proliferation and antigen-presenting cell (APC) function by overcoming the FcγRIIb dysfunction of both SLE and rheumatoid arthritis (RA) B cells. The gene discussed is FCGR2B; the disease is systemic lupus erythematosus.